Can a gut test detect IBS, SIBO or leaky gut?

Short answer: A gut test can help investigate SIBO and give a signal about the gut barrier, but it cannot diagnose IBS or “leaky gut” on its own. Which test is useful depends entirely on which condition you’re asking about.

Key takeaways

• IBS: A gut test cannot diagnose IBS by itself. IBS is a clinical diagnosis, made by a doctor from your symptom pattern once other conditions are ruled out.
• SIBO: This is the one condition here a gut test is designed to assess. A guideline-recommended hydrogen and methane breath test can evaluate small intestinal bacterial overgrowth and help guide treatment — no test is perfect, so results are read alongside your symptoms.
• Leaky gut: “Leaky gut” is not a formal medical diagnosis. A faecal (stool) zonulin marker can give a signal about the gut barrier, but it is best read alongside your symptoms, and other markers in a gut test, rather than as a firm verdict.
• The best gut microbiome test is one that helps you understand what might be contributing to your symptoms and thus helps personalise your plan, rather than labelling a condition.

If you have lived with bloating, pain or unpredictable digestion for months, it is natural to want a single test that finally names the problem. The honest answer is that a gut test helps with some of these questions but not others, because IBS, SIBO and leaky gut each mean something different. This article walks through what a gut test can, and cannot, tell you about each one, so you can choose a sensible next step.

What counts as a “gut test”?

“Gut test” is not one single thing. The phrase usually refers to one of three quite different tests, each answering a different question:

1. Stool (microbiome) test — looks at the balance and variety of bacteria in your gut, along with markers of digestion and inflammation.
2. Breath test — measures gases in your breath to check for bacterial overgrowth in the small intestine.
3. Gut-barrier marker — attempts to measure “leaky gut”, most often using a protein called zonulin.

Because these tests are so different, the answer to “can a gut test detect IBS, SIBO or leaky gut?” depends on which test you mean and which condition you are asking about. Here is each one in turn.

Can a gut test detect IBS?

No — not on its own. IBS is what doctors call a clinical diagnosis: it is based on your pattern of symptoms, once other conditions have been ruled out, and there is no single lab result that confirms it. You may like to check out our blog all about what IBS actually is and what it means for you.

UK guidance from NICE (CG61) sets this out clearly. A doctor considers IBS when you have symptoms such as abdominal pain linked to your bowel habits, along with bloating or a change in stool frequency or form. Simple tests — blood tests and a stool test for inflammatory markers such as faecal calprotectin — are used to check for other causes, such as inflammatory bowel disease or coeliac disease. Importantly, NICE describes IBS as a positive diagnosis, made on the basis of a recognisable symptom pattern once red flags are excluded — not simply a case of ruling everything else out.

A stool microbiome test cannot provide that label either. Research has found that people with IBS often show differences in their gut bacteria, but the findings are inconsistent. A large systematic review in Gastroenterology (Pittayanon et al., 2019) found that the association between the gut microbiome and IBS symptoms is not yet well established: it identified some bacterial differences between people with and without IBS, but could not determine whether these are a cause or a consequence of the condition, and the studies were highly variable. No reliable “IBS signature” has been identified.

What a stool test can do is different, and still valuable. It can highlight factors that may be contributing to your symptoms, such as low bacterial diversity or signs of poor digestion, which can help shape a personalised food, lifestyle and supplement plan. This is where expert interpretation matters. Healthpath’s Ultimate Gut Health test pairs a comprehensive stool test with a practitioner-led review of your results and symptoms, so the numbers are placed in the context of your wider health. It might be helpful to read one of our other blogs to learn more about gut microbiome tests and whether they’re worth the money.

⚠️ When to see your GP, not a test

Some symptoms are not part of IBS and need prompt medical review rather than a home test. Based on NICE guidance, see your GP promptly if you have any of the following:

• Unintentional or unexplained weight loss
• Rectal bleeding or blood in your stool
• A change in bowel habit to looser or more frequent stools, especially if you are over 60
• A family history of bowel or ovarian cancer
• Anaemia, or a lump or swelling in your tummy or back passage

These don’t necessarily mean something serious, but they do need checking before assuming your symptoms are IBS.

Can a gut test detect SIBO?

Yes — of these three conditions, SIBO is the one a gut test is genuinely designed to assess. A hydrogen and methane breath test is the standard, guideline-recommended way to evaluate small intestinal bacterial overgrowth, and specialist consensus rates it a useful, low-cost, simple and safe test. It isn’t a perfect measure, so results are best interpreted alongside your symptoms — but for the right person it’s a practical and genuinely actionable starting point.

SIBO means there are too many bacteria in the small intestine, where numbers should normally be low. How the breath test works: you drink a sugar solution, then give breath samples over a couple of hours. Gut bacteria ferment the sugar and produce gases, which pass into your blood and out through your lungs. A clear rise in hydrogen, or a raised level of methane, can suggest overgrowth. The sugar used is usually either lactulose or glucose; glucose tends to produce fewer false positives, while lactulose can assess further along the small intestine. When methane is the dominant gas, the pattern is now often called IMO, or intestinal methanogen overgrowth.

Why the test is worth doing. Leading gastroenterology bodies recommend it. The American College of Gastroenterology guideline (Pimentel et al., 2020) recommends hydrogen and methane breath testing to diagnose SIBO and IMO in symptomatic patients, and the North American Consensus (Rezaie et al., 2017) — a panel of specialists who standardised how the test is performed and read — concluded that breath testing is a useful, inexpensive and safe tool for common gut problems. The results are also clinically meaningful: hydrogen-predominant overgrowth tends to track with bloating and diarrhoea, while methane-predominant IMO is more associated with constipation, which helps direct treatment. And a breath test can do more than label the problem — the same Gastroenterology & Hepatology review (Lim & Rezaie, 2023) notes it can help tailor antibiotic therapy and predict how well someone will respond to treatment. In one study, patients positive for both hydrogen and methane had an 80% symptomatic response rate to the antibiotic rifaximin (Barkin et al., 2019), a concrete example of how test results can flag who is likely to benefit. You may like to check out our deep dive article in to the SIBO-IBS connection.

The limitations, kept in proportion. No breath test is a perfect stand-in for what’s happening in the small intestine, and it’s fair to be upfront about that. The ACG guideline grades its breath-testing recommendation as conditional, on very low-quality evidence, and notes there is no validated gold-standard test to compare against. Breath tests are also an indirect measure: as Lim and Rezaie explain, results can be influenced by how quickly food moves through your gut (orocecal transit time), which is where some false positives come from. None of this makes the test unhelpful — it makes interpretation the key. A number read in isolation can mislead; the same number read alongside your symptoms by someone who knows how to weigh it is where the value lies.

That’s exactly why Healthpath’s SIBO Test pairs the breath test with a practitioner review, so your result is interpreted in the context of your symptoms rather than left for you to decode alone.

Can a gut test detect leaky gut?

No — not as a standalone diagnosis. “Leaky gut”, known more formally as increased intestinal permeability, is a genuine area of science, but it is not a recognised standalone medical condition, so no test can hand you that label on its own. What a test can offer is a signal about your gut barrier.

Your gut lining is designed to let nutrients through while keeping unwanted contents out, and researchers do study how this barrier can become more permeable. The marker Healthpath uses to explore it is faecal zonulin, measured from a stool sample. Zonulin is a protein that helps regulate the tight junctions between gut cells (Tripathi et al., 2009), which is why it became a popular marker of barrier integrity. Measuring it in stool is non-invasive, practical and low-cost, and recent prospective work (Ciurea et al., 2025) continues to evaluate faecal zonulin as a marker of intestinal permeability, though the associations reported tend to be moderate rather than strong. In plain terms, a faecal zonulin result is a useful signal about your gut barrier — not a stand-alone diagnosis of “leaky gut” — and it works best read alongside your symptoms and other results.

It’s worth knowing that zonulin can also be measured in blood, and the blood version has attracted more criticism. Independent studies suggest the commercial blood assays may not reliably measure true zonulin, and instead pick up related proteins: one widely cited study found a common commercial ELISA did not detect the zonulin precursor and recognised properdin instead (Scheffler et al., 2018). A letter in Gut (Massier et al., 2021) argued these assays are not adequate for judging permeability. This is why any zonulin result is best interpreted by a practitioner, alongside your symptoms, rather than taken as a verdict on its own. (You can also read our separate guide on zonulin and the gut barrier for more detail.)

Which gut test is right for you?

The best test depends on your symptoms and what you want to learn. No test replaces a proper assessment of your symptoms and history — the most useful approach is to match the test to what you are experiencing, then have the results interpreted by someone qualified. This table gives a simple overview:

If you want a broad picture, the Ultimate Gut Plan offers a comprehensive microbiome test with a practitioner review. If your symptoms suggest overgrowth, the SIBO Plan is a more targeted starting point.

Frequently asked questions

What are the first signs of SIBO?

The earliest and most common signs of SIBO are bloating, excess wind, abdominal pain or discomfort, and a change in bowel habits — usually diarrhoea, or constipation when methane-producing organisms (IMO) predominate. Symptoms are often worse after meals, as bacteria ferment food and produce gas. Because these signs overlap heavily with IBS and other gut conditions, they point to something worth investigating rather than confirming SIBO on their own. Longer-standing or more severe overgrowth can also cause fatigue and poor absorption of nutrients such as vitamin B12. According to University College London Hospitals NHS Foundation Trust, SIBO is most common in people whose illness affects the movement or structure of the gut. Because the symptoms are non-specific, a hydrogen and methane breath test — interpreted alongside your symptoms — is the practical way to tell whether overgrowth is contributing.

What are the early signs of leaky gut?

There is no medically agreed list of “early signs” of leaky gut, because increased intestinal permeability is not a recognised standalone diagnosis. The symptoms people commonly attribute to it — bloating, digestive discomfort, reactions to certain foods, and fatigue — are non-specific and overlap with many gut and non-gut conditions, so they cannot confirm a “leaky gut” on their own. What a test can offer is a signal rather than a label: a faecal zonulin marker gives an indication about the gut barrier, but the research on zonulin as a biomarker is debated, so a result is best read alongside your symptoms by a practitioner rather than treated as a verdict. If your digestive symptoms are persistent, it’s worth investigating the underlying cause rather than assuming a leaky gut.

What is the biggest trigger for SIBO?

There is no single universal trigger, but the driver most consistently identified is impaired movement of the small intestine — specifically a weakened migrating motor complex, the “housekeeper” wave that sweeps bacteria and residual food through the gut between meals. When that clearing action slows, bacteria linger and can overgrow. In practice, the small intestine normally keeps bacterial numbers low through stomach acid and intestinal motility, so SIBO tends to appear when those defences are disrupted. Common specific triggers include a previous bout of food poisoning or gastroenteritis (post-infectious IBS), low stomach acid, structural or anatomical changes in the bowel, certain medications such as proton-pump inhibitors and opioids, and conditions like diabetes or scleroderma. Identifying the underlying trigger matters, because treating the overgrowth without addressing the cause often leads to it returning.

Can you have SIBO and IBS at the same time?

Yes. SIBO and IBS share many of the same symptoms and frequently occur together — small intestinal bacterial overgrowth is found more often in people with IBS than in the general population, which is why the American College of Gastroenterology guideline discusses breath testing specifically in symptomatic IBS patients. The key difference is that SIBO can be tested for with a breath test and treated with antibiotics, whereas IBS is a clinical diagnosis made from your symptom pattern once other conditions are ruled out. So being told you have IBS doesn’t rule out SIBO — for some people, a breath test uncovers a treatable driver behind symptoms that had simply been labelled “IBS”.

Does the NHS recognise SIBO?

Yes — SIBO is recognised as a genuine clinical condition within UK gastroenterology. Some NHS hospitals offer hydrogen and methane breath testing for it, and the British Society of Gastroenterology has published a standardised UK testing protocol for assessing SIBO and carbohydrate malabsorption. However, SIBO is not routinely tested for in primary care: access varies considerably around the country, usually requires a GP referral to a gastroenterologist, and waiting times can be long. Because of this inconsistency, many people choose to test privately so their result can be interpreted alongside their symptoms without a lengthy wait.

This article is for information only. It is not intended to diagnose, treat, cure or prevent any disease. Always speak to a qualified healthcare professional about your symptoms.

Scientific references

1. National Institute for Health and Care Excellence. Irritable bowel syndrome in adults: diagnosis and management (CG61). https://www.nice.org.uk/guidance/cg61
2. National Institute for Health and Care Excellence. Irritable bowel syndrome in adults, Quality standard QS114, Statement 2: Giving a diagnosis. https://www.nice.org.uk/guidance/qs114/chapter/quality-statement-2-giving-a-diagnosis
3. Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome — a systematic review. Gastroenterology. 2019;157(1):97–108. https://pubmed.ncbi.nlm.nih.gov/30940523/
4. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. American Journal of Gastroenterology. 2020;115(2):165–178. https://journals.lww.com/ajg/fulltext/2020/02000/acg_clinical_guideline__small_intestinal_bacterial.9.aspx
5. Lim J, Rezaie A. Pros and Cons of Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth. Gastroenterology & Hepatology. 2023;19(3):140–146. https://www.gastroenterologyandhepatology.net/archives/march-2023/pros-and-cons-of-breath-testing-for-small-intestinal-bacterial-overgrowth-and-intestinal-methanogen-overgrowth/
6. Tripathi A, Lammers KM, Goldblum S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences. 2009;106(39):16799–16804. https://pubmed.ncbi.nlm.nih.gov/19805376/
7. Ciurea N-A, Pantea CM, Grama P, Kosovski I-B, Bataga S. Fecal zonulin as a non-invasive marker of intestinal permeability: findings from a prospective cohort study. Medicina (Kaunas). 2025;61(9):1527. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12471543/
8. Scheffler L, Crane A, Heyne H, et al. Widely used commercial ELISA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family. Frontiers in Endocrinology. 2018;9:22. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807381/
9. Massier L, Chakaroun R, Kovacs P, Heiker JT. Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability. Gut. 2021;70(9):1801–1802. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355880/